Aspira Women’s Health grants 185,178 stock options to director

Aspira Women's Health Inc. reported an insider equity award for director Winfred Parnell.

Accepted by SEC EDGAR 12/03/2025 - 09:32 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Aspira Women's Health Inc. reported an insider equity award for director Winfred Parnell. On 12/02/2025, Parnell received a stock option to buy 185,178 shares of common stock at an exercise price of $0.35 per share. The option becomes exercisable on 12/02/2025 and expires on 12/02/2035. After this award, Parnell beneficially owned 185,178 derivative securities directly.

Insider Trade Summary

Grant/Award: 185,178 shares

Grant/Award 1 txn

Insider Parnell Winfred

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	185,178	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 185,178 contracts (Direct)

Holdings Before and After: Stock Option (Right to Buy), 0 to 185,178 contracts (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aspira Women's Health (AWHL) report in this Form 4?

The company reported that director Winfred Parnell received a stock option to purchase 185,178 shares of common stock on 12/02/2025.

What is the exercise price of the new Aspira Women's Health (AWHL) stock option?

The stock option granted to director Winfred Parnell has an exercise price of $0.35 per share.

When do the newly granted Aspira Women's Health (AWHL) options become exercisable and when do they expire?

The options become exercisable on 12/02/2025 and expire on 12/02/2035.

How many derivative securities does the Aspira Women's Health (AWHL) director own after this transaction?

Following the reported transaction, director Winfred Parnell beneficially owned 185,178 derivative securities directly.

What type of derivative security was granted to the Aspira Women's Health (AWHL) director?

The security is a stock option (right to buy) covering 185,178 shares of Aspira Women's Health common stock.

Is this Aspira Women's Health (AWHL) Form 4 filed for one reporting person or multiple?

The Form 4 is indicated as being filed by one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parnell Winfred

(Last) (First) (Middle)

C/O ASPIRA WOMEN'S HEALTH INC

12117 BEE CAVES RD, BLDG 3-100

(Street)

AUSTIN, TX 78738

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWHL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.35	12/02/2025		A		185,178		12/02/2025	12/02/2035	Common Stock	185,178	$0	185,178	D

Explanation of Responses:

	/s/ Winfred Parnell	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.